Chapter 1 Prefix
    1.1 Market Scope
    1.2 Report Description
    1.3 Research Methodology
          1.3.1 Primary Research
          1.3.2 Secondary Research
          1.3.3 In-house Data Modeling
Chapter 2 Executive Summary
Chapter 3 Market Outline
    3.1 Market Inclination, Trend, Outlook and Viewpoint
    3.2 Market Share Analysis: Company’s Competitive Scenario
    3.3 Market Dynamics
          3.3.1 Drivers
                   3.3.1.1 Impact Analysis
          3.3.2 Restraints
                   3.3.2.1 Impact Analysis
          3.3.3 Opportunities
Chapter 4 Over the Counter (OTC) Drugs Market by Type: Market Size and Forecast, 2015 – 2024
    4.1 Overview
    4.2 Analgesic & pain relieves
          4.2.1 Current Trend and Analysis
          4.2.2 Market Size and Forecast
    4.3 Dermatological products
          4.3.1 Current Trend and Analysis
          4.3.2 Market Size and Forecast
    4.4 Cough, cold, and flu products
          4.4.1 Current Trend and Analysis
          4.4.2 Market Size and Forecast
    4.5 Vitamin supplements
          4.5.1 Current Trend and Analysis
          4.5.2 Market Size and Forecast
    4.6 Mineral supplements
          4.6.1 Current Trend and Analysis
          4.6.2 Market Size and Forecast
    4.7 Ophthalmic products
          4.7.1 Current Trend and Analysis
          4.7.2 Market Size and Forecast
          4.7.3 Dry eye
                   4.7.3.1 Market Size and Forecast
          4.7.4 Glaucoma
                   4.7.4.1 Market Size and Forecast
          4.7.5 Allergic & infective drugs
                   4.7.5.1 Market Size and Forecast
          4.7.6 Other treatments
                   4.7.6.1 Market Size and Forecast
    4.8 Others (Include digestive products, sleep aids & weight loss products)
          4.8.1 Current Trend and Analysis
          4.8.2 Market Size and Forecast
Chapter 5 Over the Counter (OTC) Drugs Market by Geography: Market Size and Forecast, 2015 – 2024
    5.1 Overview
    5.2 North America
          5.2.1 Current Trend and Analysis
          5.2.2 Market Size and Forecast
          5.2.3 US
                   5.2.3.1 Market Size and Forecast
          5.2.4 Canada
                   5.2.4.1 Market Size and Forecast
          5.2.5 Mexico
                   5.2.5.1 Market Size and Forecast
    5.3 Europe
          5.3.1 Current Trend and Analysis
          5.3.2 Market Size and Forecast
          5.3.3 Germany
                   5.3.3.1 Market Size and Forecast
          5.3.4 France
                   5.3.4.1 Market Size and Forecast
          5.3.5 United Kingdom
                   5.3.5.1 Market Size and Forecast
          5.3.6 Italy
                   5.3.6.1 Market Size and Forecast
          5.3.7 Others
                   5.3.7.1 Market Size and Forecast
    5.4 Asia-Pacific
          5.4.1 Current Trend and Analysis
          5.4.2 Market Size and Forecast
          5.4.3 China
                   5.4.3.1 Market Size and Forecast
          5.4.4 India
                   5.4.4.1 Market Size and Forecast
          5.4.5 Japan
                   5.4.5.1 Market Size and Forecast
          5.4.6 Others
                   5.4.6.1 Market Size and Forecast
    5.5 RoW
          5.5.1 Current Trend and Analysis
          5.5.2 Market Size and Forecast
          5.5.3 Middle East
                   5.5.3.1 Market Size and Forecast
          5.5.4 South America
                   5.5.4.1 Market Size and Forecast
          5.5.5 Africa
                   5.5.5.1 Market Size and Forecast
Chapter 6 Company Profiles
    6.1 Lucentis
    6.2 Restacis
    6.3 Vigamox
    6.4 Sanofi
    6.5 Bayer AG
    6.6 Merck KGaA
    6.7 Novartis AG
    6.8 Pfizer, Inc.
    6.9 Johnson & Johnson Inc.
    6.10 GlaxoSmithKline Plc
    6.11 Alkem Laboratories Limited
    6.12 Teva Pharmaceutical Industries Ltd.

GET MORE INFORMATION ABOUT THIS REPORT


Refresh Captcha

Related Report